Guidance
Unavailability of intravesical BCG for treatment of bladder cancer
Information and sources of further guidance relating to the current shortage of products used in the treatment of some bladder cancers
Documents
PDF, 46.6 KB, 4 pages
This file may not be suitable for users of assistive technology.
Request an accessible format
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
A letter from Professor Sir Mike Richards, National Clinical Director for Cancer
Updates to this page
Published 9 July 2012